The answer depends on the actual product, the country and the offer. A cosmetic serum, a nutritional product, a prescription medicine and a laboratory compound do not become the same advertising category because each contains a peptide. Start with what you sell and who may buy it. Account age, creative quality and a managed advertising service cannot make an ineligible product eligible.
This guide helps an advertising team build a review brief. It does not determine a product’s regulatory status. Check the current Meta Advertising Standards before launch; resolve uncertain product classification with an appropriately qualified adviser in the countries you intend to serve.
In this guide
1. Classify the offer before writing the hook
| Offer | What to establish | What not to assume |
|---|---|---|
| Cosmetic product containing peptides | Intended use, formulation, claims, destination and applicable cosmetic/health advertising rules. | A cosmetic label permits medical or drug claims. |
| Nutrition or supplement product | Ingredients, lawful sale, permitted claims and Meta’s product and age restrictions. | Every supplement may be advertised. |
| Prescription medicine or treatment | Advertiser eligibility, licenses, authorization and permitted target markets. | A research-product store qualifies as a licensed pharmacy. |
| Laboratory research compound | Actual intended use, legal status and whether the offer is eligible for promotion. | “Research use only” overrides the substance or the sales context. |
For example, a finished topical cosmetic and a vial sold for laboratory research need separate assessments, even if their names share GHK-Cu. Keep the product’s real category consistent through the ad, product page and checkout. Do not attach consumer benefit promises to a research-only label.
2. Check the specific policy gates
Meta’s Drugs and Pharmaceuticals policy prohibits promotion of illicit or recreational drugs and substances, products or supplements Meta considers unsafe. Prescription-drug advertising follows a separate authorization route. The current policy identifies eligible advertiser types, certification or review requirements, age conditions and permitted countries. A supplier’s account designation is not a substitute for those requirements.
Keep a short eligibility record for each market: the product and formulation, intended use, seller identity, relevant permissions, destination URL and the policy reviewed. If the review finds the offer is prohibited, stop that paid-social launch. Switching the headline to general education while still directing people to buy the prohibited offer does not resolve the underlying issue.
3. Review the complete customer journey
Meta says its review can consider imagery, video, text, targeting and associated landing pages. An attractive ad does not stand apart from the page it opens. Follow the journey on a phone: headline, product description, testimonials, navigation, cart and any claims visible along the way. Source: Meta’s review process.
- The displayed product and price should match the destination. Make offer conditions easy to find.
- Support every factual quality, testing or origin statement with records that actually apply to the product shown.
- Check that mobile navigation, checkout and contact routes work before paying for traffic.
- Remove claims you cannot substantiate; do not merely move them into an image, testimonial or another page.
A batch report may support a specific test result. It does not, by itself, establish that a product is approved, safe for human use or effective for a health outcome. Keep those concepts separate in creative briefs.
4. Write about the product without diagnosing the viewer
Meta’s Privacy Violations and Personal Attributes policy restricts ads that assert or imply personal attributes, including health conditions. The practical question is whether the copy describes the offer or claims to know something sensitive about the person seeing it.
For an otherwise eligible cosmetic offer, a product-led concept such as “Meet the serum in our skincare collection” is a different approach from asserting that the viewer has a particular condition. Neither sentence is an approval template: the product, claims, imagery, audience and destination still need review. Avoid treating a word substitution as the whole compliance process.
5. Build a launch brief your whole team can use
- Record the product category, market and eligibility decision before commissioning variants.
- List the facts the creative may use and link each to its evidence.
- Approve one landing-page version and record its URL with the final creative.
- Check audience and age requirements for that exact category and destination.
- Confirm measurement permissions and event configuration; see our Pixel and CAPI guide.
- Name the person responsible for review feedback and save the submitted version.
This keeps creative production useful. A designer can explore composition, product detail and buyer questions inside a clear brief, instead of inventing an unsupported health angle. Our creative examples show ways to separate an angle from a claim; they are concepts to evaluate, not a catalog of Meta-approved ads.
6. Know what an approval actually tells you
An approved ad has passed review at that point in time. Meta states that ads may be reviewed again after going live. An active competitor ad is therefore neither a legal opinion nor proof that your product, account or landing page will be accepted. Use the Meta Ad Library to study format and messaging, not to infer permission or profitability.
If delivery stops, identify whether the issue concerns a single ad, an account, a business asset, payment or measurement. Our restriction response guide explains what to collect and which official review route to check. Keep the evidence and address the stated issue before proposing the next launch.
Where Adnoxx fits
Adnoxx brings campaign work into one dashboard for peptide brands. Evaluate the workflow around your eligible products: how a brief becomes a campaign, how your team sees its status and how reporting supports the next decision. The platform complements product review and operating discipline; Meta remains responsible for advertising eligibility and enforcement. Explore account management.